Company intelligence / Profile preview

Modern Meadow

Nutley, New Jersey, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Modern Meadow’s biomaterial platforms (Bio-Alloy™ and Bio-Coll@gen™) are commercially adopted in textiles (fashion, interiors, outdoor applications), and as cosmetic or cosmetic-ingredient actives, reliably recapitulating animal-derived properties at scale.

Industry: Non-Drug Biotech

Partnerships

Limonta (joint venture for BioFabric)Evonik (commercial biofabrication partnership)Navis TubeTex (textile finishing)Singtex (biomaterials for outdoor apparel)

Beyond the preview

Go deeper on Modern Meadow.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Modern Meadow.

Explore the full profile